nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Adenocarcinoma of the uterine cervix: Pathologic features, treatment options, clinical outcome and prognostic variables
|
Gadducci, Angiolo |
|
2019 |
135 |
C |
p. 103-114 |
artikel |
2 |
Biomarkers in Non-Schistosomiasis-related squamous cell carcinoma of the urinary bladder: A review
|
Maia, Manuel Caitano |
|
2019 |
135 |
C |
p. 76-84 |
artikel |
3 |
Cancer of the anal region
|
Valvo, Francesca |
|
2019 |
135 |
C |
p. 115-127 |
artikel |
4 |
Corrigendum to “Incidence and clinical parameters associated with eribulin mesylate-induced peripheral neuropathy” [Crit. Rev. Oncol./Hematol. 128 (August) (2018) 110–117]
|
Zhao, Bin |
|
2019 |
135 |
C |
p. 20 |
artikel |
5 |
Editorial Board
|
|
|
2019 |
135 |
C |
p. IFC |
artikel |
6 |
Effect of neoadjuvant chemotherapy on locally advanced upper tract urothelial carcinoma: A systematic review and meta-analysis
|
Kim, Do Kyung |
|
2019 |
135 |
C |
p. 59-65 |
artikel |
7 |
Impact of age on the overall survival benefits of anti-EGFR-containing regimens in head and neck squamous cell carcinoma: A meta-analysis of randomized controlled trials
|
Zhao, Yuguang |
|
2019 |
135 |
C |
p. 39-46 |
artikel |
8 |
Leptomeningeal carcinomatosis in patients with breast cancer
|
Franzoi, Maria Alice |
|
2019 |
135 |
C |
p. 85-94 |
artikel |
9 |
PD-1/PD-L1 immune-checkpoint inhibitors in glioblastoma: A concise review
|
Caccese, Mario |
|
2019 |
135 |
C |
p. 128-134 |
artikel |
10 |
Platinum salts in the treatment of BRCA-associated breast cancer: A true targeted chemotherapy?
|
Torrisi, Rosalba |
|
2019 |
135 |
C |
p. 66-75 |
artikel |
11 |
Primarily resectable pancreatic adenocarcinoma – to operate or to refer the patient to an oncologist?
|
Piątek, Michał |
|
2019 |
135 |
C |
p. 95-102 |
artikel |
12 |
Primary extranodal lymphoma of the glands. Literature review and options for best practice in 2019
|
Belkacemi, Yazid |
|
2019 |
135 |
C |
p. 8-19 |
artikel |
13 |
Programmed cell death protein receptor and ligands in haematological malignancies – Current status
|
Sokołowski, Marcin |
|
2019 |
135 |
C |
p. 47-58 |
artikel |
14 |
Tackling molecular targets beyond PD-1/PD-L1: Novel approaches to boost patients’ response to cancer immunotherapy
|
Omar, Hany A. |
|
2019 |
135 |
C |
p. 21-29 |
artikel |
15 |
The roles of EBV-encoded microRNAs in EBV-associated tumors
|
Dong, Min |
|
2019 |
135 |
C |
p. 30-38 |
artikel |
16 |
Tinnitus during and after childhood cancer: A systematic review
|
Meijer, Annelot J.M. |
|
2019 |
135 |
C |
p. 1-7 |
artikel |